exv99

THE CHINA FUND, INC. (CHN)

The Martin Currie
Shanghai team

IN BRIEF


Net asset value per share	US	$52.86
Market price	US	$43.99
Premium/(discount)		(16.78	%)
Fund size	US	$770.4	m


Source: State Street Corporation



At 31 August 2007		US$ returns


	China Fund NAV		MSCI Golden Dragon*
	%		%
One month		4.1		2.0
Year to date		63.0		23.7
One year		100.5		53.5
Three years %pa		43.4		29.4


Past performance is not a guide to future returns.

Source: State Street Corporation. NAV-NAV performance.

*Source for index data: MSCI.

MANAGER’S COMMENTARY

Martin Currie acts as portfolio manager of The China Fund, Inc. (“Fund”). This commentary is the opinion of Martin Currie Inc.

August was an exciting month in China. In addition to the well-publicised problems associated with the souring of collateralised debt obligations (CDOs), there was the surprising news that individual Chinese are to be allowed to invest directly offshore, as well as worrying signs of a build-up in inflationary pressures. This resulted in high market volatility and a wide spread in market returns; the domestic A-share market, unperturbed, ended the month at a new high; the Hang Seng ended up 7.7%; Taiwan fell by 1.2%.

It is not surprising that the A-share market was unfazed by CDO problems, and the associated deleveraging of global hedge funds; after all, foreign investors still own less than 1% of this market, first-half earnings growth was over 70%, and real interest rates remain negative for local savers. What is more of a mystery is why the market was unaffected by the news of a pilot scheme, via Bank of China’s Tianjin branch, that will allow individuals to invest directly in Hong Kong. In its most radical interpretation, this move is tantamount to ending capital controls, which currently trap renminbi savings in the local asset markets. However, local investors probably bet, with some justification, that implementation of the scheme will be slow and under strict controls (there are already rumours that the minimum investment will be 300,000 renminbi, the equivalent of nearly US$40,000, and so well out of the reach of all but the very wealthiest Chinese). Investors in Hong Kong took the opposite view and bid up H-shares by 30% in the two weeks following the announcement.

More worrying for us is the acceleration in inflation; the consumer price index reached +5.6% in July and looks likely to top 6% in August. Although this inflation is led by food (+15.4%), exacerbated by pig disease and floods, there are signs that inflationary sentiment is widening and is likely to persist. This is not a good environment for supporting a highly rated market. In the near term, however, increasing inflation and the strong trade performance are likely to embolden the leadership to accelerate renminbi appreciation somewhat, though no ‘courageous’ decisions are likely to be taken ahead of the 17th Party Congress beginning on 15 October.

Despite being the cheapest market, and a long-term underperformer, Taiwan came off worst in the correction. This was despite favourable political news (Kuomintang presidential candidate Ma Ying-jeou was found not guilty of misuse of government expenses) and a good set of interim results. Some of the Taiwan insurers admitted to ownership of sub-prime mortgages, and suffered accordingly, though the amount they own is dwarfed by that held by the state-owned banks on the mainland — which performed well!

INVESTMENT STRATEGY

The Fund is 94.5% invested with holdings in 70 companies. The Fund held a relatively large amount of cash during August — the reflection of our caution about markets. We raised money from the A-share market, cutting our weighting further to 19.6%, crystallising large capital gains in the process. Following the Fed’s discount rate cut mid-month, we bought heavily in Taiwan and Hong Kong. Our purchases in Taiwan included China Development (Taiwan’s largest venture-capital company), China Metal, Data Systems (software for enterprise resource planning) and Efun (prism film for LCD backlights). In Hong Kong, we added to the depressed Zijin Mining, Yorkey (optical components) and Chinasoft. In the B-share market, we sold property company Lujiazui in favour of the world’s largest container-maker, CMIC. We briefly held Wuxi Pharmaceutical (a drug-testing company), which was the month’s ‘hot’ initial public offering on the Nasdaq.

Chris Ruffle, Martin Currie Inc*


*		Martin Currie Ltd and Heartland Capital Management Ltd (HCML) have established MC China Ltd (MCCL), as a joint venture company, to provide investment management or investment advisory services to the range of China investment products managed by Martin Currie.

		MCCL has appointed Martin Currie Investment Management Ltd (MCIM), or its affiliates, as investment manager of Martin Currie’s China investment products.

		HMCL has seconded both Chris Ruffle and Shifeng Ke to MCIM or its affiliates on a full time basis with the same roles and responsibilities as if they were full time employees.

31 AUGUST 2007

FUND DETAILS


Market cap		US$641.2m
Shares outstanding		14,575,961
Exchange listed	NYSE
Listing date	July 10, 1992
Investment adviser	Martin Currie Inc

Source: State Street Corporation.

ASSET ALLOCATION


Source: State Street Corporation

SECTOR ALLOCATION


	The China			MSCI Golden
	Fund, Inc			Dragon
Industrials		23.6	%		10.0	%
Consumer discretionary		14.4	%		5.5	%
Financials		13.1	%		31.7	%
Energy		12.0	%		8.3	%
Healthcare		8.4	%		—
Information technology		7.5	%		22.8	%
Consumer staples		6.4	%		1.3	%
Materials		5.6	%		7.7	%
Utilities		3.5	%		3.9	%
Telecommunications		—			8.8	%
Other assets & liabilities		5.5	%		—
Total		100.0	%		100.0	%


Source: State Street Corporation. Source for index data: MSCI



PERFORMANCE		(US$ RETURNS)


	NAV		Market price
	%		%
One month		4.1		0.4
Year to date		63.0		28.7
Three years %pa		43.4		28.6


Past performance is not a guide to future returns.

Source: State Street Corporation

DIRECT INVESTMENTS (0.4%)


Sino-Twinwood	Information technology	0.4	%
teco Optronics	Information technology	—

15 LARGEST LISTED INVESTMENTS (35.7%)


Synnex Technology	Retail	3.2	%
China Oilfield Services	Industrials	3.2	%
Daqin Railway	Industrials	3.1	%
Shanghai International Airport	Industrials	2.9	%
Chaoda Modern Agriculture	Consumer staples	2.6	%
Far Eastern Department Stores	Consumer discretionary	2.3	%
Golden Meditech	Healthcare	2.2	%
Xinjiang Tebian Electric	Industrials	2.1	%
Uni-President Enterprises	Consumer discretionary	2.1	%
Shanghai Zhenhua Port Machinery	Industrials	2.0	%
China Petroleum & Chemical	Energy	2.0	%
Xinao Gas	Energy	2.0	%
China Merchants Bank	Financials	2.0	%
Far East Energy	Energy	2.0	%
Yuanta Financial	Financials	2.0	%


Source: State Street Corporation



FUND PERFORMANCE (BASED ON NET ASSET VALUE)		(US$ RETURNS)


	One		Three		Calendar		One		Three		Five		Since
	month		months		year to date		year		years		years		launch
	%		%		%		%		% pa		% pa		% pa
The China Fund, Inc.		4.1		21.4		63.0		100.5		43.4		38.4		13.9
MSCI Golden Dragon		2.0		18.3		23.7		53.5		29.4		24.6		n/a
Hang Seng Chinese Enterprise		7.7		33.8		38.3		107.8		49.5		49.5		n/a
Shanghai Stock Exchange 180		20.4		38.9		155.9		308.7		73.6		32.9		n/a


Past performance is not a guide to future returns.

Source: State Street Corporation. Launch date 10 July 1992. Three year, five year and since launch returns are all annualised.

Source for index data: MSCI for the MSCI Golden Dragon and Copyright 2007 Bloomberg LP for the Hang Seng Chinese Enterprise and the Shanghai Stock Exchange 180. For a full description of each index please see the index descriptions section.

PERFORMANCE IN PERSPECTIVE


Past performance is not a guide to future returns.

Source: Martin Currie Inc as at 31 August 2007.

THE CHINA FUND INC. PREMIUM/DISCOUNT


Past performance is not a guide to future returns.

Source: Martin Currie Inc as at 31 August 2007.

10 YEAR DIVIDEND HISTORY CHART


Total	0.50	0.08	0.11	0.00	0.13	0.21	1.78	3.58	2.51	4.01
Income	0.50	0.08	0.11	0.00	0.13	0.06	0.07	0.20	0.22	0.30
Long-term capital	0.00	0.00	0.00	0.00	0.00	0.00	0.67	3.27	2.29	2.73
Short-term capital	0.00	0.00	0.00	0.00	0.00	0.15	1.04	0.11	0.00	0.98


Past performance is not a guide to future returns.

Source: State Street Corporation.

31 AUGUST 2007


Sector	Company (BBG ticker)	Price		Holding		Value $		% of portfolio
Hong Kong									19.1	%
Chaoda Modern Agriculture	682 HK	HK$6.0			26,407,900		20,354,802		2.6	%
Golden Meditech	8180 HK	HK$3.7			35,040,000		16,807,156		2.2	%
Xinao Gas	2688 HK	HK$12.9			9,286,000		15,315,395		2.0	%
China Travel International	0308 HK	HK$4.9			18,148,000		11,474,512		1.5	%
Huabao International	336 HK	HK$6.8			12,790,000		11,137,786		1.5	%
Tianjin Development	0882 HK	HK$9.1			8,440,000		9,882,612		1.3	%
Parkson Retail	3368 HK	HK$62.4			1,111,500		8,888,009		1.2	%
TPV Technology	903 HK	HK$4.9			12,728,000		7,982,291		1.0	%
China Shineway Pharmaceutical	2877 HK	HK$5.2			11,184,000		7,401,256		1.0	%
Ports Design	589 HK	HK$21.1			2,678,500		7,231,065		0.9	%
Natural Beauty Bio-Technology	157 HK	HK$1.7			32,780,000		7,062,798		0.9	%
Shangri-La Asia	0069 HK	HK$18.6			2,975,555		6,412,866		0.8	%
Yorkey Optical International	2788 HK	HK$2.4			15,838,000		4,874,950		0.6	%
Fountain Set	420 HK	HK$3.0			12,446,000		4,836,498		0.6	%
China Rare Earth	769 HK	HK$2.1			15,254,000		4,206,111		0.6	%
Chinasoft International	8216 HK	HK$1.8			10,500,000		2,410,465		0.3	%
Ocean Grand Chemicals	2882 HK	HK$0.3			17,379,000		690,947		0.1	%
Arcontech	8097 HK		—		18,386,000		—		—

China ‘B’ shares									2.1	%
Shanghai Lujiazui Finance	900932 SHA	HK$2.4			3,530,706		8,579,616		1.1	%
China International Marine Containers	200039 CH	HK$17.0			3,450,000		7,521,883		1.0	%

Singapore									3.7	%
Yangzijiang Shipbuilding	YZJ SP	SG$1.9			9,546,000		11,649,866		1.5	%
Hsu Fu Chi International	HFCI SP	SG$1.1			8,409,000		6,013,916		0.8	%
Bio-Treat Technology	BIOT SP	SG$0.9			10,615,000		5,954,875		0.8	%
CDW	CDW SP	US$0.1			60,000,000		4,724,099		0.6	%

Hong Kong ‘H’ shares									12.1	%
China Oilfield Services	2883 HK	HK$15.0			12,650,000		24,335,503		3.2	%
China Petroleum & Chemical	386 HK	HK$8.5			14,120,000		15,392,606		2.0	%
China Shenhua Energy	1088 HK	HK$33.8			3,435,000		14,890,250		1.9	%
Zhejiang Expressway	576 HK	HK$10.4			10,304,000		13,690,653		1.8	%
BYD	1211 HK	HK$56.4			1,368,500		9,890,022		1.3	%
Zijin Mining	2899 HK	HK$6.9			10,408,000		9,183,627		1.2	%
Anhui Expressway	995 HK	HK$6.6			6,780,000		5,747,642		0.7	%

Taiwan									31.1	%
Synnex Technology	2347 TT	NT$90.6			8,905,050		24,449,151		3.2	%
Far Eastern Department Stores	2903 TT	NT$33.0			17,630,080		17,603,901		2.3	%
Uni-President Enterprises	1216 TT	NT$38.3			14,137,220		16,386,820		2.1	%
Yuanta Financial	2885 TT	HK$18.8			26,413,545		15,048,173		2.0	%
China Development Financial	2883 TT	NT$13.5			35,798,000		14,590,839		1.9	%
Powertech Technology	6239 TT	NT$132.5			3,581,100		14,379,095		1.9	%
Data Systems Consulting	2447 TT	NT$43.5			10,146,718		13,375,625		1.7	%
Cathay Financial	2882 TT	NT$73.5			5,708,370		12,714,482		1.6	%
China Metal Products	1532 TT	NT$48.8			8,392,675		12,411,362		1.6	%
Tripod Technology	3044 TT	NT$136.0			2,974,083		12,257,198		1.6	%
Merry Electronics	2439 TT	NT$112.0			3,584,340		12,165,401		1.6	%
Asia Optical	3019 TT	NT$122.5			3,159,153		11,727,514		1.5	%
Fubon Financial	2881 TT	NT$28.5			12,603,000		10,865,643		1.4	%
Taiwan Secom	9917 TT	NT$54.5			4,738,000		7,825,116		1.0	%
Formosa Petrochemical	6505 TT	NT$92.0			2,658,000		7,410,406		0.9	%
China Synthetic Rubber	2104 TT	NT$41.7			5,294,000		6,689,894		0.9	%
Efun Technology	3523 TT	NT$197.0			997,100		6,670,197		0.9	%
Lien Hwa Industrial	1229 TT	NT$19.5			11,161,855		6,595,841		0.8	%
Wah Lee Industrial	3010 TT	NT$73.7			2,838,856		6,340,304		0.8	%
Taiwan FamilyMart	5903 TT	NT$51.0			3,557,652		5,498,356		0.7	%
Yieh United Steel	9957 TT	NT$18.5			9,483,000		5,316,388		0.7	%

United Kingdom									1.4	%
China Medical System Holdings	CMSH LN		£1.4		3,623,188		10,558,182		1.4	%

United States									5.0	%
Far East Energy	FEEC US	US$1.4			11,111,111		15,111,111		2.0	%
Mindray Medical International	MR US	US$35.5			367,000		13,024,830		1.6	%
China Medical Technologies	CMED US	HK$34.3			271,500		9,309,735		1.2	%
Chindex International	CHDX US	US$20.6			69,987		1,439,632		0.2	%


Sector	Company (BBG ticker)	Price		Holding		Value $		% of portfolio
Equity linked securities (‘A’ shares)									19.6	%
Daqin Railway			US$2.4		9,710,000		23,575,880		3.1	%
Shanghai International Airport			US$5.6		4,066,100		22,550,590		2.9	%
Xinjiang Tebian Electric			US$7.0		2,370,642		16,516,263		2.1	%
Shanghai Zhenhua Port Machinery			US$3.5		4,462,752		15,534,840		2.0	%
China Merchants Bank			US$5.0		3,033,555		15,286,084		2.0	%
Finance Street			US$5.1		2,736,453		14,065,368		1.8	%
Qinghai Salt Lake Potash			US$6.4		1,725,209		10,974,055		1.4	%
China Yangtze Power			US$2.6		4,169,077		10,677,006		1.4	%
Baoding Tianwei Baobian Electric			US$4.7		1,947,486		8,843,421		1.2	%
Shanghai International Port			US$1.3		5,499,923		7,231,189		1.0	%
Shanghai Tunnel Engineering			US$2.1		3,441,747		5,369,125		0.7	%

Direct									0.4	%
Sino-Twinwood			US$6.1		500,000		3,050,000		0.4	%
teco Optronics			—		1,861,710		—		—

Other assets & liabilities							42,441,143		5.5	%

INDEX DESCRIPTIONS

MSCI Golden Dragon Index

The MSCI Golden Dragon is a free float-adjusted market capitalisation index that is designed to measure equity market performance in the China region. As of May 2005 the MSCI Golden Dragon Index consisted of the following country indices: China, Hong Kong and Taiwan.

Hang Seng China Enterprise Index

The Hang Seng China Enterprise Index is a capitalisation-weighted index comprised of state-owned Chinese companies (H-shares) listed on the Hong Kong Stock Exchange and included in HSMLCI index.

Shanghai Stock Exchange 180 Index

The Shanghai Stock Exchange 180 ‘A’ Share Index is a capitalisation-weighted index. The index tracks the daily price performance of the 180 most representative ‘A’ share stocks listed on the Shanghai Stock Exchange.

OBJECTIVE

The investment objective of the Fund is to achieve long term capital appreciation through investment in companies and other entities with significant assets, investments, production activities, trading or other business interests in China or which derive a significant part of their revenue from China.

The Board of Directors of the Fund has adopted an operating policy of the Fund, effective 30 June 2001, that the Fund will invest at least 80% of its assets in China companies. For this purpose, “China companies” are (i) companies for which the principal securities trading market is in China; (ii) companies for which the principal securities trading market is outside of China or in companies organised outside of China, that in both cases derive at least 50% of their revenues from goods or services sold or produced, or have a least 50% of their assets in China; or (iii) companies organised in China. Under the policy, China will mean the People’s Republic of China, including Hong Kong, and Taiwan. The Fund will provide its stockholders with at least 60 days’ prior notice of any change to the policy described above.

The fundamental policy, which applies to not less than 65% of the Fund’s assets as set out in the Fund’s prospectus dated 27 June 2005, remains in place. The fundamental policy is the same as the operating policy set out above, except that China only includes the People’s Republic of China and Hong Kong.

The Fund is subject to the Investment Company Act of 1940 which limits the means in which it can access the ‘A’ share market. The Fund will continue to seek the most efficient way in which to increase its ‘A’ share exposure ensuring ongoing compliance with its legal and regulatory obligations.

CONTACTS

The China Fund, Inc.
c/o State Street Bank and Trust Company
2 Avenue de Lafayette, 6th Floor
PO Box 5049
Boston, MA 02206-5049
Tel: (1) 888 CHN-CALL (246 2255)
www.chinafundinc.com

Important information: This document is issued and approved by Martin Currie Inc (MC Inc), as investment adviser of the China Fund Inc (the Fund). MC Inc is authorised and regulated by the Financial Services Authority (FSA) and incorporated under limited liability in New York, USA. Registered in Scotland (No BR2575), registered address Saltire Court, 20 Castle Terrace, Edinburgh, EH1 2ES. Information herein is believed to be reliable but has not been verified by MC Inc. MC Inc makes no representation or warranty and does not accept any responsibility in relation to such information or for opinion or conclusion which the reader may draw from the newsletter.

Martin Currie Ltd and Heartland Capital Management Ltd (HCML) have established MC China Ltd (MCCL), as a joint venture company, to provide investment management or investment advisory services to our China product. MCCL has appointed Martin Currie Investment Management Ltd (MCIM), or its affiliates, as investment manager of our China funds. HMCL has seconded both Chris Ruffle and Shifeng Ke to MCIM or its affiliates on a full time basis with the same roles and responsibilities as if they were full time employees.

The Fund is classified as a ‘non-diversified’ investment company under the US Investment Company Act of 1940. It meets the criteria of a closed ended US mutual fund and its shares are listed on the New York Stock Exchange. MC Inc has been appointed investment adviser to the Fund.

Investors are advised that they will not generally benefit from the rules and regulations of the United Kingdom Financial Services and Markets Act 2000 and the FSA for the protection of investors, nor benefit from the United Kingdom Financial Services Compensation Scheme, nor have access to the Financial Services Ombudsman in the event of a dispute. Investors will also have no rights of cancellation under the FSA’s Conduct of Business Sourcebook of the United Kingdom.

This newsletter does not constitute an offer of shares. MC Inc, its ultimate and intermediate holding companies, subsidiaries, affiliates, clients, directors or staff may, at any time, have a position in the market referred to herein, and may buy or sell securities, currencies, or any other financial instruments in such markets. The information or opinion expressed in this newsletter should not be construed to be a recommendation to buy or sell the securities, commodities, currencies or financial instruments referred to herein.

The information provided in this report should not be considered a recommendation to purchase or sell any particular security. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased.

It should not be assumed that any of the securities transactions or holdings discussed here were or will prove to be profitable, or that the investment recommendations or decisions we make in the future will be profitable or will equal the investment performance of the securities discussed herein.

Investing in the Fund involves certain considerations in addition to the risks normally associated with making investments in securities. The value of the shares issued by the Fund, and the income from them, may go down as well as up and there can be no assurance that upon sale, or otherwise, investors will receive back the amount originally invested. There can be no assurance that you will receive comparable performance returns, or that investments will reflect the performance of the stock examples contained in this document. Movements in foreign exchange rates may have a separate effect, unfavorable as well as favorable, on the gain or loss otherwise experienced on an investment. Past performance is not a guide to future returns. Accordingly, the Fund is only suitable for investment by investors who are able and willing to withstand the total loss of their investment. In particular, prospective investors should consider the following risks:

è		The companies quoted on Greater Chinese stock exchanges are exposed to the risks of political, social and religious instability, expropriation of assets or nationalisation, rapid rates of inflation, high interest rates, currency depreciation and fluctuations and changes in taxation, which may affect income and the value of investments.

è		At present, the securities market and the regulatory framework for the securities industry in China is at an early stage of development. The CSRC is responsible for supervising the national securities markets and producing relevant regulations. The Investment Regulations, under which the Fund invests in the People’s Republic of China (‘PRC’) and which regulate repatriation and currency conversion, are new. The Investment Regulations give CSRC and SAFE wide discretions and there is no precedent or certainty as to how these discretions might be exercised, either now or in the future. The Fund may, from time to time, obtain access to the securities markets in China via Access Products. Such products carry additional risk and may be less liquid than the underlying securities which they represent.

è		During the past 15 years, the PRC government has been reforming the economic and political systems of the PRC, and these reforms are expected to continue, as evidenced by the recently announced changes. The fund’s operations and financial results could be adversely affected by adjustments in the PRC’s state plans, political, economic and social conditions, changes in the policies of the PRC government such as changes in laws and regulations (or the interpretation thereof), measures which may be introduced to control inflation, changes in the rate or method of taxation, imposition of additional restrictions on currency conversion and the imposition of additional import restrictions.

è		PRC’s disclosure and regulatory standards are in many respects less stringent than standards in certain OECD countries, and there may be less publicly available or less reliable information about PRC companies than is regularly published by or about companies from OECD countries.

è		The Shanghai Stock Exchange and Shenzhen Stock Exchange have lower trading volumes than most OECD exchanges and the market capitalisations of listed companies are small compared to those on more developed exchanges in developed markets. The listed equity securities of many companies in the PRC are accordingly materially less liquid, subject to greater dealing spreads and experience materially greater volatility than those of OECD countries. These factors could negatively affect the Fund’s NAV.

è		The Fund invests primarily in securities denominated in other currencies but its NAV will be quoted in US dollars. Accordingly, a change in the value of such securities against US dollars will result in a corresponding change in the US dollar NAV.

è		The marketability of quoted shares may be limited due to foreign investment restrictions, wide dealing spreads, exchange controls, foreign ownership restrictions, the restricted opening of stock exchanges and a narrow range of investors. Trading volume may be lower than on more developed stockmarkets, and equities are less liquid. Volatility of prices can also be greater than in more developed stockmarkets. The infrastructure for clearing, settlement and registration on the primary and secondary markets may be underdeveloped. Under certain circumstances, there may be delays in settling transactions in some of the markets.

è		The value of the fund’s investment in any Quota will be affected by taxation levied against the relevant QFIIs or in respect of investments held in the relevant Quotas. The PRC taxation regime that will apply to QFIIs and investments made in or through QFII quotas is not clear. The Investment Regulations are new and do not currently expressly contemplate the treatment of QFIIs and investment made through QFII Quotas.

è		It should be noted that the position with regard to PRC taxation of the Company and its gains and profits remains unclear. Until such time as the PRC taxation position of the Company is clarified, the Company will process all subscription and redemption requests based upon provisional Net Asset Value calculations, determined without making any provision for PRC capital gains taxation, but with a provision for withholding tax of 10% on all dividend income received. The number of Ordinary shares allotted to any investor, and the final redemption price per share, will be recalculated upon the taxation position being clarified. The Company will require an indemnity in respect of such amount of any redemption proceeds as they consider prudent to allow for potential PRC taxation liabilities that may be included in the final Net Asset Value calculation.

		In practice this means that, should any tax be payable retrospectively, the Company’s Net Asset Value will be adjusted to the extent that existing shareholders are liable. All shareholders will be required to sign an indemnity prior to being permitted to redeem all or part of their shareholding to protect the Company and the existing shareholders. Any change to the withholding tax rate which is applied to the Company on an retrospective basis will result in an adjustment of the Net Asset Value of the Company for the benefit of, or if charged at a higher rate than the existing provision, detriment of existing shareholders.

Although Martin Currie complies with the Global Investment Performance Standards (GIPS), the fund returns used in this document are calculated on the net asset value and therefore fall outside the scope of the GIPS standards.

Martin Currie Inc, registered in Scotland (no BR2575)

Registered office: Saltire Court, 20 Castle Terrace, Edinburgh EH11 2ES Tel: (44) 131 229 5252 Fax: (44) 131 222 2532 www.martincurrie.com/china
North American office: 1350 Avenue of the Americas, Suite 3010, New York, NY 10019, USA Tel: (1) 212 258 1900 Fax: (1) 212 258 1919

Authorised and registered by the Financial Services Authority and incorporated with limited liability in New York, USA.
Please note: calls to the above numbers may be recorded.